Tower Research Capital LLC (Trc) Reviva Pharmaceuticals Holdings, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $3.29 Billion
- Q1 2025
A detailed history of Tower Research Capital LLC (Trc) transactions in Reviva Pharmaceuticals Holdings, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 8,247 shares of RVPH stock, worth $3,381. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8,247
Previous 26,775
69.2%
Holding current value
$3,381
Previous $46,000
84.78%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding RVPH
# of Institutions
58Shares Held
8.04MCall Options Held
938KPut Options Held
40.8K-
Vanguard Group Inc Valley Forge, PA1.8MShares$739,6770.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.53MShares$629,0690.0% of portfolio
-
Diadema Partners LP Morristown, NJ651KShares$266,7960.16% of portfolio
-
Persistent Asset Partners LTD Hong Kong, K3641KShares$262,8810.18% of portfolio
-
Tang Capital Management LLC San Diego, CA510KShares$209,2340.03% of portfolio
About REVIVA PHARMACEUTICALS HOLDINGS, INC.
- Ticker RVPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,442,900
- Market Cap $8.38M
- Description
- Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is RP506...